ziftomenib
kura oncology
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'komet-001', 'ko,met,01', 'ko,met,001', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'ziftomenib']
late breaking abstract at #eha2023 dr. amir fathi presented komet-001phase 1/2 of ziftomenib (menu inhibitor) in relapsed or refractory aml 
Director of Pediatric BMT @ClevelandClinic #CleClinicCancer @cleclinickids #CleClinicPedsCancer #ChildhoodCancer #pedcsm #bmtsm Tweets = my own opinion.